Discontinued — last reported Q4 '25
Total Cost of Revenue
Cost of RevenueEli Lilly Total Cost of Revenue increased by 12.1% to $3.37B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 40.3%, from $2.40B to $3.37B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 10.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase relative to revenue suggests declining efficiency or rising input costs, whereas a decrease suggests better operational scaling.
Detailed definition
The direct costs associated with producing and delivering the goods and services sold by the company. This typically inc...
Peer comparison
Cloud-heavy companies monitor this closely as a measure of data center and infrastructure efficiency.
is_total_cost_of_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.95B | $1.43B | $2.05B | $2.07B | $1.43B | $1.58B | $1.55B | $1.63B | $1.81B | $1.86B | $1.79B | $1.67B | $2.17B | $2.17B | $2.40B | $2.22B | $2.45B | $3.01B | $3.37B |
| QoQ Change | — | -26.7% | +43.3% | +1.1% | -31.0% | +10.4% | -2.0% | +5.1% | +11.1% | +2.9% | -3.9% | -6.4% | +29.7% | +0.0% | +10.7% | -7.5% | +10.1% | +22.9% | +12.1% |
| YoY Change | — | — | — | — | -26.8% | +10.4% | -24.5% | -21.5% | +26.3% | +17.8% | +15.5% | +2.9% | +20.1% | +16.7% | +34.4% | +32.9% | +12.8% | +38.6% | +40.3% |
Business Segments
Total Cost of Revenue at Other Companies
Frequently Asked Questions
- What is Eli Lilly's total cost of revenue?
- Eli Lilly (LLY) reported total cost of revenue of $3.37B in Q4 2025.
- How has Eli Lilly's total cost of revenue changed year-over-year?
- Eli Lilly's total cost of revenue increased by 40.3% year-over-year, from $2.40B to $3.37B.
- What is the long-term trend for Eli Lilly's total cost of revenue?
- Over 4 years (2021 to 2025), Eli Lilly's total cost of revenue has grown at a 10.9% compound annual growth rate (CAGR), from $7.31B to $11.05B.
- What does total cost of revenue mean?
- The direct expenses a company pays to create and deliver what it sells.